Thursday, November 21 2024
Breaking News
ESMO’22 Recommended Abstracts in RENAL CANCERS
Gene activity Can Provide Clues for Risk of Kidney Cancer Spreading
A 20-year retrospective: How Kidney Cancer Journal Reflected on Advances in The Therapeutic Strategies
2022 ESMO: Promise and Pitfalls of Adjuvant Immunotherapy
Optimal Duration of Therapy in Metastatic RCC: Exploring Treatment-Free Survival with Checkpoint Inhibitors
Kidney Cancer Research Highlights from ASCO 2022 Annual Meeting
Engineered T-Cell Therapy: The Next Direction for RCC Immuno-oncology?
Comparison of Papillary Renal Cell Carcinoma Type 1 and Type 2: A Secondary Data Analysis
Recent Advances in Tivozanib plus Nivolumab Combinatorial Strategies in Renal Cell Carcinoma
From Gene Discovery to a FDA approval; Belzutifan’s Fascinating Journey at UTSW
Search for
Switch skin
Sidebar
Random Article
Menu
Search for
Home
Cancer
Prostate Cancer
Renal Cancer
Bladder Cancer
Penile Cancer
Testicular Cancer
Upper Tract Tumors
Investigative Urology
CRPC w/ Bone Metastases
GU CANCERS
Spotlight
Urology
Kidney Cancer
Bladder Cancer
OAB/INCONTINENCE
COVID19-Cancer
SUO Annual Meeting
Conferences
ASCO
ESMO
APCCC
GLOBAL SOC OF GU TUMORS
SUO –AUA
Bladder Cancer Advocacy Network (BCAN), IBCN
EAU Section of Oncological Urology
ESOU
Clinical Trials
FDA News
COVID-19 & cancer
Guidelines
UroWeb guide
EU Oncology
Resource Center
Urosource
Opinion
NEWS
Media
CME/CE
Search for
Follow
Nothing Found
It seems we can’t find what you’re looking for. Perhaps searching can help.
Search for:
Back to top button
Close
Search for
Close
Search for
